Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
NCT06613737
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza A H3N2
Interventions
OTHER:
Influenza A H3N2 virus dose arm 1
OTHER:
Influenza A H3N2 virus dose arm 2
OTHER:
Influenza A H3N2 virus dose arm 3
Sponsor
Hvivo